Aberdeen Asset
Management: Aberdeen
continues to advance, with the latest step being this year’s debt and equity
funded £606.6m acquisition of the SWIP investment arm. This move resulted in
AUM jumping 62% to £324.4bn, although this masks underlying significant redemptions
from ‘Old Aberdeen’ and ongoing client defections at SWIP. In these results to
30th September 2014, net revenue was up 4% at £1.12bn, with
underlying PBT up 2% at £490.3m. Underlying eps were a slight beat, but were down
4% to 31.1p, whilst the total dividend has been increased by 12.5% to 18p. So,
this dividend is almost twice covered (1.7x) by earnings and backed by a cash
pile (including c£400m regulatory capital) that grew from £426.6m to £653.9m.
Sentiment on emerging markets has worsened as QE tapering in the US developed.
For Aberdeen their Asian bias has been a hindrance. SWIP will help even out
this imbalance, but will fuzz Aberdeen’s specialist image. This is reflected in
the average management fee falling to 41.8 bps, with the second half (so with
SWIP fully included) showing a rate of 36.9bps. The outlook is one of those that can be
characterises as cautiously optimistic.
It looks like FY2015 forecasts are settling at 35p and a bit, being
growth of 12.5% and putting the shares on 13.2x at 460p. If cover is held at
1.7x, this gives a dividend of 20.6p for a yield of 4.5%. It is not
unreasonable to look at similar growth in FY2016 and FY2017 as underlying
growth is blended with efficiencies and cost savings at SWIP. Before the SWIP
deal the company’s management had been guiding that acquisition led growth was
over and that organic progress was favoured. The temptation provided by the SWIP
opportunity was too great, but shareholders must be hoping that the dust will
now be allowed to settle for at least the 18 months suggested by management. So,
whilst capital returns were not mentioned in this release, the assumption must
still be that shareholders can expect more cash returns given the strong
balance sheet and cash generation. The multiples are no longer compelling but
equally are not stretched. Unless you have the glums about equities and
emerging markets, then for dividend growth investors, Aberdeen Asst Management still
looks like it meets the requirements. (Neil Cumming, 2nd December 2014)
These comments are not a personal recommendation to deal. Any
investments can fall as well as rise in value, so you could get back less than
you invest. I may have a financial interest in some of the stocks written
about. www.dividendpower.co.uk
or e-mail at info@dividendpower.co.uk Twitter:
@DividendPower
No comments:
Post a Comment